Atlas Trials

Benefit of Transcutaneous Auricular Vagus Nerve Stimulation in Improving Quality of Life in First Line Treatment of Ovarian Cancer:

Clinical trial NCT06817161 · RECRUITING

Trial details

NCT number
NCT06817161
Sponsor
Centre Francois Baclesse
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Ovarian CarcinomaFirst Line ChemotherapyDigestive System Disorders
Start date
2025-04-30
Primary completion
2028-06-30
Enrollment
116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.